Search

Your search keyword '"Baechler S"' showing total 72 results

Search Constraints

Start Over You searched for: Author "Baechler S" Remove constraint Author: "Baechler S" Database MEDLINE Remove constraint Database: MEDLINE
72 results on '"Baechler S"'

Search Results

1. Illuminating the dark web market of fraudulent identity documents and personal information: An international and Australian perspective.

2. Mitochondrial topoisomerase I (Top1MT) prevents the onset of metabolic dysfunction-associated steatohepatitis (MASH) in mice.

3. Cross-border forensic profiling of fraudulent identity and travel documents: A pilot project between France and Switzerland.

4. Forensic intelligence teaching and learning in higher education: An international approach.

5. An efficient method to detect series of fraudulent identity documents based on digitised forensic data.

6. Understanding Australian methylamphetamine drug markets through relational, temporal and spatial analyses.

7. Determining the impact of unknown individuals in criminality using network analysis of DNA matches.

8. MODELLING THE EXPOSURE OF RESIDENTS OF A RADIUM-CONTAMINATED LIVING PLACE.

9. Breaking the barriers between intelligence, investigation and evaluation: A continuous approach to define the contribution and scope of forensic science.

10. Must the random man be unrelated? A lingering misconception in forensic genetics.

11. Touch DNA collection - Performance of four different swabs.

12. Management of crime scene units by Quebec police senior managers: Insight on forensic knowledge and understanding of key stakeholders.

13. The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis.

14. First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68 Ga-NODAGA-MJ9.

15. Model of ambient dose equivalent for radium contamination: Dependence on the geometry of the source.

16. Determination of 226 Ra at low levels in environmental, urine, and human bone samples and 223 Ra in bone biopsy using alpha-spectrometry and metrological traceability to 229 Th/ 225 Ra or 226 Ra.

17. First in-human radiation dosimetry of 68 Ga-NODAGA-RGDyK.

18. Dose assessment following an overexposure of a worker at a Swiss nuclear power plant.

19. Smartphone and Tablet Applications for Crime Scene Investigation: State of the Art, Typology, and Assessment Criteria.

20. Calculation of the maximum allowed ambient dose rate outside CT rooms to quantitatively assess the structural shielding performance.

21. CONVERTING SPECIFIC ACTIVITY INTO AMBIENT DOSE EQUIVALENT: UPDATED COEFFICIENTS FOR IN SITU GAMMA SPECTROMETRY.

22. REMEDIATION OF RADIUM LEGACIES FROM THE SWISS WATCH INDUSTRY.

24. Modeling of geogenic radon in Switzerland based on ordered logistic regression.

25. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.

26. Chemical profiling: A tool to decipher the structure and organisation of illicit drug markets: An 8-year study in Western Switzerland.

27. OCCUPATIONAL EXPOSURE TO EXTERNAL RADIATION IN SWITZERLAND.

28. Image processing of false identity documents for forensic intelligence.

29. Development of a systematic computer vision-based method to analyse and compare images of false identity documents for forensic intelligence purposes-Part I: Acquisition, calibration and validation issues.

30. (210)Po poisoning as possible cause of death: forensic investigations and toxicological analysis of the remains of Yasser Arafat.

31. Study of criteria influencing the success rate of DNA swabs in operational conditions: A contribution to an evidence-based approach to crime scene investigation and triage.

32. Calibration of the Politrack® system based on CR39 solid-state nuclear track detectors for passive indoor radon concentration measurements.

33. Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry.

34. Improved predictive mapping of indoor radon concentrations using ensemble regression trees based on automatic clustering of geological units.

35. Forensic intelligence framework. Part II: Study of the main generic building blocks and challenges through the examples of illicit drugs and false identity documents monitoring.

36. Predictive analysis and mapping of indoor radon concentrations in a complex environment using kernel estimation: an application to Switzerland.

37. Monte Carlo simulation of a whole-body counter using IGOR phantoms.

38. Occupational and patient exposure as well as image quality for full spine examinations with the EOS imaging system.

39. Forensic intelligence framework--Part I: Induction of a transversal model by comparing illicit drugs and false identity documents monitoring.

40. Major influencing factors of indoor radon concentrations in Switzerland.

41. Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.

42. Redefining Relative Biological Effectiveness in the Context of the EQDX Formalism: Implications for Alpha-Particle Emitter Therapy.

44. The systematic profiling of false identity documents: method validation and performance evaluation using seizures known to originate from common and different sources.

45. Anthocyanins suppress the cleavable complex formation by irinotecan and diminish its DNA-strand-breaking activity in the colon of Wistar rats.

46. Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.

47. Modulation of the cellular redox status by the Alternaria toxins alternariol and alternariol monomethyl ether.

48. Biokinetics and dosimetry of 111In-DOTA-NOC-ATE compared with 111In-DTPA-octreotide.

49. Three-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy.

50. Longer intervals between hematopoietic stem cell transplantation and subsequent 90Y-ibritumomab radioimmunotherapy may correlate with better tolerance.

Catalog

Books, media, physical & digital resources